Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.42 USD | -3.55% | +14.43% | +40.29% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 18 | Verastem Oncology Announces Executive Changes | CI |
Evolution of the average Target Price on Verastem, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Verastem, Inc.
Truist Securities | |
B. Riley | |
RBC Capital Markets | |
Mizuho Securities | |
HC Wainwright | |
BTIG | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- VSTM Stock
- Consensus Verastem, Inc.